Renalytix AI (RNLX) just unveiled an announcement.
Renalytix plc announced a significant milestone as Medicare issued its final coverage determination for the company’s innovative product, kidneyintelX.dkd. This breakthrough could impact investors and market-watchers, highlighting a potential growth avenue for Renalytix amidst the healthcare sector’s evolving landscape.
See more data about RNLX stock on TipRanks’ Stock Analysis page.